Search
For optimal search results, please limit to 2 product keywords
If you are searching for information related to a product:
- For optimal results, please enter at least 2 search terms in addition to product name
- Example: [product name] [search term] [search term]
- Example: Product + clinical trials
- For an exact match, please include search terms in double quotations. For example: "Elevatum"
Diffuse large B-cell lymphoma (DLBCL)
Follicular lymphoma (FL)
Mantle Cell Lymphoma (MCL)
The list of publications is not an exhaustive list of published materials on the product. The list of references by data topics is selected per evidence-based medicine criteria.
To browse a full listing of published scientific literature: Visit PubMed
3L+ FL
Long-term 3-year follow-up of mosunetuzumab in relapsed or refractory follicular...
Sehn LH, Bartlett NL, Matasar MJ, et al
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Dickinson MJ, Carlo-Stella C, Morschhauser F, et al
AE Management
Seamless Navigation of Bispecific Therapies
Zahra Mahmoudjafari 1, Amir Ali 2, James Davis 3, et al
Consensus Recommendations
Jennifer L. Crombie Tara Graff , Lorenzo Falchi , Yasmin H. Karimi, et al
Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With...
Franck Morschhauser et al
Operationalization
Operationalization and Use of Bispecific T-Cell Engaging Antibodies in Community Practices: Multidisciplinary...
William Donnellan, MD, Shih-Wen Lin, PhD, Jonathan Abbas, MD, et al
MorningSun Coordination of Care
Tara Graff 1, Ian Flinn 2, Jeff P Sharman 3, et al
R/R DLBCL
Mosunetuzumab with polatuzumab vedotin in relapsed or refractory aggressive large B cell...
Budde LE, Olszewski AJ, Assouline S, et al
Looking for more information?
Reach out to a Genentech Medical Science Liaison near you, or connect with the contact center.
Call Us: 1-800-821-8590 Hours: Monday-Friday, 5am-5pm PT
